This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: La Trobe University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Paul John Hertzog: Innovator in Cancer Diagnosis and Treatment
Introduction
Paul John Hertzog is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of metastatic cancer. His innovative approach has the potential to improve patient outcomes and advance medical science.
Latest Patents
Hertzog holds a patent for a method of diagnosis and treatment related to metastatic cancer. This invention focuses on diagnosing, prognosing, and monitoring the development of bone metastatic cancer. The method involves detecting metastatic cancer or a predisposition to it by screening for the differential expression of a panel of genes that comprise an IRF7 binding site. Additionally, the invention provides a means of therapeutically or prophylactically treating metastatic cancer by upregulating type I IFN levels.
Career Highlights
Hertzog is affiliated with La Trobe University, where he contributes to research and development in the field of cancer treatment. His work has garnered attention for its innovative approach to addressing complex medical challenges. With 1 patent to his name, he continues to push the boundaries of cancer research.
Collaborations
Hertzog collaborates with Belinda Sheree Parker, working together to advance their research initiatives. Their partnership exemplifies the importance of teamwork in scientific discovery.
Conclusion
Paul John Hertzog is a pioneering inventor whose work in cancer diagnosis and treatment holds promise for improving patient care. His innovative methods and collaborations reflect a commitment to advancing medical science and enhancing the understanding of metastatic cancer.